Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease

In Alzheimer disease (AD) research and care, novel biomarkers that measure amyloid-β (Aβ) and phosphorylated tau (P-tau)–the principal components of amyloid plaques and neurofibrillary tangles–have facilitated early detection and biomarker-supported diagnosis.1 Therapeutics that modify the biology.....